Frontiers in Neuroscience | Neuropharmacology

Original Research

Published on 28 Jul 2023

Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions

in Neuropharmacology

Daniela Vázquez-González
Juan Carlos Corona

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1186520

2,604 views
5 citations

Mini Review

Published on 24 Jul 2023

Attenuation of ferroptosis as a potential therapeutic target for neuropsychiatric manifestations of post-COVID syndrome

in Neuropharmacology

Ricardo A. L. Sousa
Asmaa Yehia
Osama A. Abulseoud

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1237153

3,353 views
6 citations

Editorial

Published on 21 Jul 2023

Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies

in Neuropharmacology

Erxi Wu
Ronghu Ke
Dan Qi
Jason H. Huang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1254881

1,540 views
2 citations

Editorial

Published on 18 Jul 2023

Editorial: What does it take to cure the brain? Studies toward genes, proteins, processes, and rehabilitation

in Neuropharmacology

Xinhua Shu
Nunzio Denora
Valentino Laquintana

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1252955

1,109 views

Systematic Review

Published on 14 Jul 2023

The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature

in Neuropharmacology

Steven McGuigan
Daniel J. Marie
Liam J. O'Bryan
Francisco J. Flores
Lisbeth Evered
Brendan Silbert
David A. Scott

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1225191

5,004 views
9 citations

Review

Published on 13 Jul 2023

Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea

in Neuropharmacology

Piotr Kaczmarski
Marcin Sochal
Dominik Strzelecki
Piotr Białasiewicz
Agata Gabryelska

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1213971

12,577 views
21 citations

Original Research

Published on 11 Jul 2023

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder

in Neuropharmacology

Maria Gałuszko-Wȩgielnik
Katarzyna Jakuszkowiak-Wojten
Mariusz Stanisław Wiglusz
Wiesław Jerzy Cubała
Michał Pastuszak

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1214972

2,819 views
5 citations

Editorial

Published on 07 Jul 2023

Editorial: Innovative treatments for neuro-psychiatric diseases

in Neuropharmacology

Lucia Gozzo
Edoardo Spina
Filippo Drago

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1247681

1,770 views
1 citation

Original Research

Published on 30 Jun 2023

In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression

in Neuropharmacology

José Ramón Gutiérrez-Casares
Cristina Segú-Vergés
Juncal Sabate Chueca
Tamara Pozo-Rubio
Mireia Coma
Carmen Montoto
Javier Quintero

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1118253

5,238 views
2 citations

Review

Published on 29 Jun 2023

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors

in Neuropharmacology

Yanting Zhou
Hongyan Li

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1227049

4,225 views
8 citations

Review

Published on 28 Jun 2023

Granulocyte colony-stimulating factor effects on neurological and motor function in animals with spinal cord injury: a systematic review and meta-analysis

in Neuropharmacology

Jing-Wei Tao
Xiao Fan
Jing-Ya Zhou
Lu-Yao Huo
Yan-Jun Mo
Hui-Zhong Bai
Yi Zhao
Jing-Pei Ren
Xiao-Hong Mu
Lin Xu

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1168764

2,795 views
7 citations

Original Research

Published on 26 Jun 2023

Mapping trends and hotspots of mitochondrial dysfunction in Alzheimer’s disease from 2013 to 2022: a bibliometric analysis of global research

in Neuropharmacology

Wang Guo
Liban Abdulle Hassan
Yu-hao Chu
Xue-ping Yang
Sheng-xue Wang
Han-xiao Zhu
Yun Li

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1199625

4,009 views
4 citations

Review

Published on 23 Jun 2023

Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article

in Neuropharmacology

Shokufeh Bagheri
Rasool Haddadi
Sahar Saki
Masoumeh Kourosh-Arami
Masome Rashno
Ali Mojaver
Alireza Komaki

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1188839

29,652 views
24 citations

Original Research

Published on 22 Jun 2023

Galantamine ameliorates hyperoxia-induced brain injury in neonatal mice

in Neuropharmacology

Nahla Zaghloul
Naomi S. Cohen
Kamesh R. Ayasolla
Hsiu-Ling Li
Dalibor Kurepa
Mohamed N. Ahmed

Frontiers in Neuroscience

doi 10.3389/fnins.2023.890015

3,066 views
8 citations

Original Research

Published on 16 Jun 2023

Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder

in Neuropharmacology

Jenika Staben
Megan Koch
Keelee Reid
Jessica Muckerheide
Lauren Gilman
Finn McGuinness
Sarina Kiesser
Iain W. H. Oswald
Kevin A. Koby
Thomas J. Martin

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1185737

9,513 views
14 citations

Opinion

Published on 13 Jun 2023

Subicular circuit in epilepsy: deconstruct heterogeneity for precise therapeutics

in Neuropharmacology

Ying Wang
Mengru Liu
Qingyu Wang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1202372

1,214 views